N-(2-Cyanoethyl)tryptamine
Pharmaceutical compound
From Wikipedia, the free encyclopedia
N-(2-Cyanoethyl)tryptamine (CE-T) is a serotonin receptor modulator and possible psychedelic drug of the tryptamine family related to tryptamine (T).[1][2][3][4] It is the N-(2-cyanoethyl) derivative of tryptamine.[1][2][3][4]
- None
| Clinical data | |
|---|---|
| Other names | N-2-Cyanoethyltryptamine; N-Cyanoethyltryptamine; CE-T; CET |
| Drug class | Serotonin receptor agonist; Monoamine releasing agent |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C13H15N3 |
| Molar mass | 213.284 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
The drug acts as a prodrug of tryptamine and hence is a non-selective serotonin receptor agonist and monoamine releasing agent similarly.[1][2][3][4] It shows greatly sustained tryptamine levels and neurochemical effects in rodents compared to tryptamine itself however.[3][1][4][2] Peak levels of tryptamine with CE-T in the brain were lower than tryptamine itself, whereas total exposure to tryptamine with CE-T in the brain was no different than with tryptamine itself in rodents.[3] CE-T alters brain serotonin and dopamine levels similarly to tryptamine, whereas both drugs have limited effects on brain norepinephrine levels.[3] It produces hypolocomotion in rodents similarly to the combination of tryptamine with a monoamine oxidase inhibitor (MAOI).[4] However, whereas tryptamine was unable to produce hypolocomotion without an MAOI, CE-T showed hypolocomotion regardless of whether the MAOI clorgiline was co-administered.[4]
CE-T was first described in the scientific literature by 1985.[2][3][1][4]
See also
- Substituted tryptamine
- N-(2-Cyanoethyl)phenethylamine (CEPEA or CE-PEA)
- Fenproporex (N-(2-cyanoethyl)amphetamine)
- N-Phosphonooxymethyl-DMT (N-POM-DMT)